Impax Asset Management Group
AMED

Impax Asset Management Group’s Amedisys AMED Stock Holding History

Impax Asset Management Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-70,000
Closed -$6.4M – 396
2023
Q2 		$6.4M Sell
70,000
-70,000
-50% -$5.74M 0.03% 190
2023
Q1 		$10.3M Buy
140,000
+25,000
+22% +$2.16M 0.04% 155
2022
Q4 		$9.61M Sell
115,000
-386,937
-77% -$34.9M 0.04% 160
2022
Q3 		$48.5M Buy
+501,937
New +$59.9M 0.25% 83

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Impax Asset Management Group's AMED Position: Q3 2023 in Review

Impax Asset Management Group sold out of Amedisys (AMED) in Q3 2023, closing a stake of 70,000 shares — an estimated $6.4M sold.

Impax Asset Management Group first reported a position in AMED in Q3 2022 and held it in 4 quarters. The position peaked at $48.5M in Q3 2022. 287 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Impax Asset Management Group reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Impax Asset Management Group sold 70,000 Amedisys shares in Q3 2023, an estimated $6.4M.
  • Impax Asset Management Group first reported a position in Amedisys in Q3 2022 and held it in 4 quarters.
  • Impax Asset Management Group's Amedisys position peaked at $48.5M in Q3 2022.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Impax Asset Management Group's 13F filing for Q3 2023, filed 7 Nov 2023.